Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Terfonyl: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Terfonyl - General Information

One of the short-acting sulfonamides used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections. [PubChem]

 

Pharmacology of Terfonyl

Terfonyl is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus.

 

Additional information about Terfonyl

Terfonyl Indication

For the treatment of rheumatic fever and meningococcal meningitis

Mechanism Of Action
Terfonyl is a competitive inhibitor of bacterial para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid.
Generic Name
Sulfadiazine
Synonyms
Sulfadiazin; Sulfadiazene; Sulfanilamidopyrimidine; Sulfapirimidin; Sulfapyrimidine; Sulfapyrimidin; Sulphadiazine; SDA
Drug Category
Antiprotozoals; Anti-Infectives
Drug Type
Small Molecule; Approved
Other Brand Names containing Sulfadiazine
Adiazin; Adiazine; Coco-Diazine; Cocodiazine; Codiazine; Cremodiazine; Cremotres; Debenal; Deltazina; Diazin; Diazolone; Diazovit; Diazyl; Eskadiazine; Honey Diazine; Lantrisul; Lipo-Diazine; Lipo-Levazine; Liquadiazine; Metha-Meridiazine; Microsulfon; Neazine; Neotrizine; Palatrize; Pecta-Diazine; Piridisir; Pirimal; Pyrimal; Quadetts; Quadramoid; Sanodiazine; Spofadrizine; Sterazine; Sulfacombin; Sulfaloid; Sulfatryl; Sulfazine; Sulfolex; Sulfonamides Duplex; Sulfonsol; Sulfose; Terfonyl; Theradiazine; Tri-Sulfameth; Trifonamide; Triple Sulfa; Triple Sulfas; Triple Sulfoid; Trisem; Truozine; Sulfa-Triple;
Toxicity (Overdose)
Oral LD50 in mouse is 1500 mg/kg.
Chemical IUPAC Name
4-amino-N-pyrimidin-2-ylbenzenesulfonamide
Chemical Formula
C10H10N4O2S
Organisms Affected
Enteric bacteria and other eubacteria